The global market for hemoconcentrators will pass the USD 12 billion mark by 2027, assesses DelveInsight

The global market for hemoconcentrators is anticipated to rise due to the increasing prevalence and burden of cardiovascular diseases, the increase in the geriatric population, and increasing technological advancements, among others.

New York, USA, Jan. 3, 2023 (GLOBE NEWSWIRE) — The global market for hemoconcentrators will pass the USD 12 billion mark by 2027, assesses DelveInsight

The global market for hemoconcentrators is anticipated to rise due to the increasing prevalence and burden of cardiovascular diseases, the increase in the geriatric population, and increasing technological advancements, among others.

by DelveInsight Hemoconcentrator Market Outlook The report provides the current and forecast market analysis, market shares of individual leading Hemoconcentrator companies, challenges, Hemoconcentrator market drivers, barriers, and trends, and key Hemoconcentrator companies in the market.

Key conclusions of the Hemoconcentrators Market report

• According to DelveInsight analysis, the global hemoconcentrator market is expected to grow at a rate CAGR of 3.76% during the forecast period (2022-2027).

• According to DelveInsight estimates, North America is anticipated to dominate the global hemoconcentrator market during the forecast period.

• Leading hemoconcentrator companies such as MEDIVATORS Inc., Terumo Cardiovascular Systems Corporation, Getinge AB, Minntech Corporation, LivaNova PLC, Nipro Asia, Medica SpA, Braile Biomédica, Andocor, TEMED, and several others are currently operating in the hemoconcentrator market.

To read more about the latest highlights related to the hemoconcentrator market, get a snapshot of the key highlights involved in the Global Hemoconcentrator Market Report

Summary of hemoconcentrators

A hemoconcentrator, also known as a hemofilter or ultrafiltration device, is made up of a semi-permeable membrane that allows the transfer of electrolytes and water from the blood. It is mainly used to remove unwanted fluids during cardiovascular bypass surgery. Hemoconcentrators can communicate with the cardiopulmonary bypass (CPB) circuit in several ways. It is usually connected to an extracorporeal circuit to monitor hemodilution and help maintain hematocrit levels. The use of a hemoconcentrator reduces the need for additional blood and homologous blood products after surgery because these devices preserve albumin, platelets, and clotting factors. Hemoconcentrators reduce potassium loss while reducing edema, organ dysfunction, and protein concentration.

the story continues

Hemoconcentration mechanisms are widely used in cardiopulmonary surgery to control and influence hemodilution and are now widely used by many surgeons and perfusionists throughout the world. Hemoconcentrators are easy-to-use devices that can be easily controlled and help reduce complications associated with postoperative bleeding.

Hemoconcentrator Market Outlook

North America is expected to account for the largest share of the global hemoconcentrator market among all regions. The growing number of surgeries, the demand for advanced technologies in extracorporeal circulation equipment, and other factors are driving regional growth.

Additionally, the risk of developing cardiopulmonary disease in the United States is increasing dramatically due to changing lifestyles and an aging population. This suggests that chronic diseases will affect the majority of Americans for decades to come. This situation has created an urgent need for hemoconcentrators to prevent and treat chronic diseases.

Furthermore, Europe and the Asia-Pacific region have the highest potential for future growth in the global hemoconcentrator market. This is due to the increasing burden of cardiovascular diseases in European and Asian countries.

To learn more about why North America is leading the growth of the hemoconcentrator market, get a snapshot of the Hemoconcentrator Market Outlook

Dynamics of the hemoconcentrator market

The hemoconcentrator market is experiencing increased product demand for a variety of reasons. Cardiovascular Surgery is becoming more common, requiring extracorporeal circulation (CPB), which provides a bloodless field for cardiac surgery. The development of extracorporeal circulation has allowed advances in cardiac surgery.

Furthermore, companies are increasing its research and development to create more effective and simple products. It’s more, COVID-19 Demand for hemoconcentrators has increased. Advanced technology helps new patient populations, such as COVID-19 patients and others who require lung support. As a result, such initiatives companies and regulatory authorities They are expected to help the hemoconcentrator market and patients in their treatment, thus driving the growth of the hemoconcentrator market.

However, certain factors, such as the need for trained professionals Y complications during surgerythey represent less of an impediment to the growth of the hemoconcentrator market.

Take a look at the dynamics of the hemoconcentrator market @ Analysis of the hemoconcentrator market dynamics

Evaluation of the hemoconcentrator market

• Segmentation of the hemoconcentrator market

  • Market segmentation by product type: Pediatric Hemoconcentrators, Adult Hemoconcentrators

  • Market segmentation by end user: Hospitals, Ambulatory Surgical Centers, Others

  • Market segmentation by geography: North America, Europe, Asia-Pacific and rest of the world

• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL Points of View, Analyst Point of View

Which key MedTech players in the hemoconcentrator market will emerge as the trendsetter explores @ Hemoconcentrator companies

Table of Contents

Interested in learning about the hemoconcentrator market for 2027? Click for a snapshot of the Hemoconcentrators Market Trends

Related reports

Implantable Cardiac Monitors (ICM) Market

Implantable Cardiac Monitors (ICM) Market Outlook, Competitive Landscape, and Market Forecast: 2027 The report offers an in-depth understanding of the implantable cardiac monitor (ICM) market trends, market drivers, market barriers and key companies, including Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, among others.

Cardiac Biomarker Testing Market

Cardiac biomarker tests Market Outlook, Competitive Landscape, and Market Forecast: 2027 The report offers an in-depth understanding of the market trends, market drivers, market barriers, and key Cardiac Biomarker Testing companies, including Beckman Coulter, Inc., Siemens Healthcare GmbH, Abbott, among others.

Angio Suites Market

Angio Suites Market Insight, Competitive Landscape and Market Forecast – 2027 The report offers a deep understanding of the market trends, market drivers, market barriers and key Angio Suite companies, including Siemens, Koninklijke Philips NV, Lam Vascular and Associates, Hitachi, Ltd., ESAOTE SPA, IMRIS, Onex Corporation, among others.

Intracardiac Echocardiography Device Market

Intracardiac echocardiography devices Market Outlook, Competitive Landscape, and Market Forecast: 2027 The report offers an in-depth understanding of the market trends, market drivers, market barriers, and key intracardiac echocardiography device companies, including Medtronic, Infraredx, Inc., Stryker, among others.

Cardiac Arrhythmia Monitoring Device Market

Cardiac Arrhythmia Monitoring Devices Market Outlook, Competitive Landscape, and Market Forecast: 2027 The report offers an in-depth understanding of the market trends, market drivers, market barriers, and key Cardiac Arrhythmia Monitoring Device companies, including Abbott Laboratories, Boston Scientific Corporation, Avanos Medical, among others.

Cardiac Resynchronization Therapy (CRT) Market

Cardiac resynchronization therapy (CRT) Market Outlook, Competitive Landscape, and Market Forecast: 2027 The report offers an in-depth understanding of the market trends, market drivers, market barriers, and key Cardiac Resynchronization Therapy (CRT) companies, including Abbott, Medtronic, Boston Scientific Corporation, BIOTRONIK, among others.

Other trend reports

Congestive Heart Failure (CHF) Market | Pulmonary Arterial Hypertension Market | Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) Market | Barlow Syndrome Market | Ebstein’s anomaly | Kounis Syndrome Market | Restrictive Cardiomyopathy Market | Rheumatic Heart Disease Market | Hypertension Portal Market | unstable angina market | Dilated Cardiomyopathy Market | Cardiogenic Shock Market | Chronic Pulmonary Hypertension Market | Abdominal Aortic Aneurysm Market

Health Care Related Blogs

Upcoming drugs for cardiovascular diseases

Key Companies in the Cardiology Segment

heart failure market

The best cardiac devices on the market

Related health services

Health Consulting

Healthcare Competitive Intelligence Services

Healthcare asset prioritization services

About DelveInsight

DelveInsight is a leading business consultancy and market research firm focused exclusively on the life sciences. It supports pharmaceutical companies by providing comprehensive end-to-end solutions to improve their performance.

CONTACT: Contact Us Shruti Thakur  info@delveinsight.com  +1(919)321-6187  https://www.delveinsight.com/medical-devices